BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20618314)

  • 1. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial.
    Wu S; Godfrey EM; Wojdyla D; Dong J; Cong J; Wang C; von Hertzen H
    BJOG; 2010 Sep; 117(10):1205-10. PubMed ID: 20618314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
    Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
    Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception.
    Turok DK; Gurtcheff SE; Handley E; Simonsen SE; Sok C; Murphy P
    Contraception; 2010 Dec; 82(6):520-5. PubMed ID: 21074014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post coital contraception.
    Haspels AA; Van Santen MR
    J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study.
    Envall N; Groes Kofoed N; Kopp-Kallner H
    Acta Obstet Gynecol Scand; 2016 Aug; 95(8):887-93. PubMed ID: 27109900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
    Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
    Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The copper T380A intrauterine device in women with type II diabetes mellitus.
    Kjos SL; Ballagh SA; La Cour M; Xiang A; Mishell DR
    Obstet Gynecol; 1994 Dec; 84(6):1006-9. PubMed ID: 7970454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine devices.
    Bilian X
    Best Pract Res Clin Obstet Gynaecol; 2002 Apr; 16(2):155-68. PubMed ID: 12041959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
    Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK
    Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochrane systematic reviews of IUD trials: lessons learned.
    Grimes DA; Lopez LM; Manion C; Schulz KF
    Contraception; 2007 Jun; 75(6 Suppl):S55-9. PubMed ID: 17531618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interception by post-coital IUD insertion.
    Van Santen MR; Haspels AA
    Contracept Deliv Syst; 1981 Jul; 2(3):189-200. PubMed ID: 12278905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
    Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate postabortion intrauterine contraception in nulliparous adolescents.
    Goldman JA; Dekel A; Reichman J
    Isr J Med Sci; 1979 Jun; 15(6):522-5. PubMed ID: 457386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.